Ceva receives EU marketing authorization granted by the EU Commission for Cirbloc® M Hyo, a new Ready To Use vaccine to protect pigs against PCV2 and Mycoplasma hyopneumoniae
The new vaccine is based on the PCV2d genotype, the most circulating one in the field and on the Mycoplasma hyopneumoniae (M. hyo) strain BA 2940.